These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15058695)

  • 21. [Hypotensive crisis].
    Herren T
    Schweiz Med Wochenschr; 1993 May; 123(17):853-67. PubMed ID: 8497772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygen transport in cardiogenic and septic shock.
    Edwards JD
    Crit Care Med; 1991 May; 19(5):658-63. PubMed ID: 2026028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shock, a clinical syndrome. Part I: definition, etiology, and pathophysiology.
    Rice V
    Crit Care Nurse; 1981; 1(3):44-50. PubMed ID: 7030628
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of hydrocortisone in periodic hemodialysis].
    Legnani F
    Minerva Med; 1972 Nov; 63(79):4320-3. PubMed ID: 5087197
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequential physiologic interactions in pediatric cardiogenic and septic shock.
    Carcillo JA; Pollack MM; Ruttimann UE; Fields AI
    Crit Care Med; 1989 Jan; 17(1):12-6. PubMed ID: 2909315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucocorticoids in prophylaxis and therapy of different kinds of shock].
    Beickert A
    Dtsch Gesundheitsw; 1970 Oct; 25(44):2061-7. PubMed ID: 4923491
    [No Abstract]   [Full Text] [Related]  

  • 27. Shock: a practical approach.
    Schwartz RA; Cerra FB
    Urol Clin North Am; 1983 Feb; 10(1):89-100. PubMed ID: 6340319
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodynamic Analysis of Pediatric Septic Shock and Cardiogenic Shock Using Transpulmonary Thermodilution.
    Lee EP; Hsia SH; Lin JJ; Chan OW; Lee J; Lin CY; Wu HP
    Biomed Res Int; 2017; 2017():3613475. PubMed ID: 28401152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock.
    Sharshar T; Gray F; Lorin de la Grandmaison G; Hopkinson NS; Ross E; Dorandeu A; Orlikowski D; Raphael JC; Gajdos P; Annane D
    Lancet; 2003 Nov; 362(9398):1799-805. PubMed ID: 14654318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotension during noncardiac anesthesia in the cardiac patient.
    Gaines GY; Giesecke AH
    Contemp Anesth Pract; 1980; 2():101-19. PubMed ID: 7002459
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry.
    Lauridsen MD; Gammelager H; Schmidt M; Nielsen H; Christiansen CF
    BMC Med Res Methodol; 2015 Mar; 15():23. PubMed ID: 25888061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
    Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
    Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
    Martínez-Brotóns F; Oncins JR; Mestres J; Amargós V; Reynaldo C
    Thromb Haemost; 1987 Aug; 58(2):709-13. PubMed ID: 3672421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytosis without anemia in a patient presenting with anaphylactic shock.
    Yanagawa Y; Sakamoto T; Okada Y
    Am J Emerg Med; 2005 Oct; 23(6):763-6. PubMed ID: 16182985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cause-specific management of shock.
    Pinsky MR
    Postgrad Med; 1983 Apr; 73(4):127-35, 138-40, 145 passim. PubMed ID: 6835869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septic, hemorrhagic and cardiogenic shock. Etiology, physiopathology, diagnosis, treatment].
    Mercat A; Richard C
    Rev Prat; 1992 Sep; 42(13):1709-14. PubMed ID: 1455146
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of endothelins in septic, cardiogenic, and hemorrhagic shock.
    Magder S; Cernacek P
    Can J Physiol Pharmacol; 2003 Jun; 81(6):635-43. PubMed ID: 12839274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infusion treatment in shock].
    Esser H
    Infusionsther Klin Ernahr; 1975 Dec; 2(6):424-8. PubMed ID: 1344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of scoring systems in patients with cardiogenic and septic shock.
    Pilz G; Stäblein A; Reuschel-Janetschek E; Autenrieth G; Werdan K
    Prog Clin Biol Res; 1989; 308():625-31. PubMed ID: 2780718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.